242 Wythe Ave #4, Brooklyn, NY 11249
1-090-1197-9528
office@ourbusiness.com

INDACO BIO

Indaco Bio Fund invests in the development of innovative pharmacological therapies. All therapeutic indications are covered, with particular attention to Oncology, CNS, Ophthalmology, Metabolic diseases, Virology and Infectious diseases.

Investments are focused on the Italian Biotech sector with select investments in other European countries, USA, Canada or Israel.

2022

Begining of operation

2032

Fund Term

€97M

AUM (first closing)

TEAM
Davide Turco
Co-Founder
Managing Director
Elizabeth Robinson
Co-Founder
Vice Chairman
Rizzo
Giovanni Rizzo
Partner Indaco BIO Fund
4026_050
Lukas Hill
Associate
COLLABORATIONS
Advisor: Biotech Venture Advisors S.r.l.

Indaco Bio Fund Investment Committee is supported by Biotech Venture Advisors S.r.l. which is made of highly professionals with scientific background and Biotech track record advising on the investment opportunities and supporting the Portfolio Companies.

Advisor Team
Rizzo
Giovanni Rizzo
Partner Indaco BIO Fund & CEO Biotech Venture Advisors S.r.l.
PORTFOLIO